title: Exclusive chemoradiotherapy for patients with medically inoperable early-stage oesophageal cancer.
authors.forename: G
authors.initials: G
authors.lastname: Crehange
authors.forename: K
authors.initials: K
authors.lastname: Peignaux
authors.forename: M
authors.initials: M
authors.lastname: Bosset
authors.forename: S
authors.initials: S
authors.lastname: Servagi-Vernat
authors.forename: J F
authors.initials: JF
authors.lastname: Bosset
authors.forename: P
authors.initials: P
authors.lastname: Maingon
mesh_terms: D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D002945:Cisplatin; D005472:Fluorouracil